JP2010512859A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512859A5 JP2010512859A5 JP2009541680A JP2009541680A JP2010512859A5 JP 2010512859 A5 JP2010512859 A5 JP 2010512859A5 JP 2009541680 A JP2009541680 A JP 2009541680A JP 2009541680 A JP2009541680 A JP 2009541680A JP 2010512859 A5 JP2010512859 A5 JP 2010512859A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue augmentation
- implant
- polymer
- agents
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 claims 14
- 210000001519 tissue Anatomy 0.000 claims 13
- 230000003416 augmentation Effects 0.000 claims 11
- 229920000642 polymer Polymers 0.000 claims 10
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- 206010046996 Varicose vein Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000003732 agents acting on the eye Substances 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000003356 anti-rheumatic effect Effects 0.000 claims 1
- 230000002921 anti-spasmodic effect Effects 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000003435 antirheumatic agent Substances 0.000 claims 1
- 230000003190 augmentative effect Effects 0.000 claims 1
- 229920005601 base polymer Polymers 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 239000000337 buffer salt Substances 0.000 claims 1
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- 239000000812 cholinergic antagonist Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims 1
- 239000000824 cytostatic agent Substances 0.000 claims 1
- 239000002274 desiccant Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 208000014617 hemorrhoid Diseases 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 229960003151 mercaptamine Drugs 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 229940125702 ophthalmic agent Drugs 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- -1 softener Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 208000027185 varicose disease Diseases 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87153406P | 2006-12-22 | 2006-12-22 | |
| ATA2136/2006 | 2006-12-22 | ||
| US60/871,534 | 2006-12-22 | ||
| AT21362006 | 2006-12-22 | ||
| PCT/AT2007/000585 WO2008077172A2 (en) | 2006-12-22 | 2007-12-21 | Use of polymers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512859A JP2010512859A (ja) | 2010-04-30 |
| JP2010512859A5 true JP2010512859A5 (enExample) | 2011-02-17 |
| JP5513893B2 JP5513893B2 (ja) | 2014-06-04 |
Family
ID=41514873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541680A Active JP5513893B2 (ja) | 2006-12-22 | 2007-12-21 | 組織増大用インプラント |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9597277B2 (enExample) |
| EP (1) | EP2107913B1 (enExample) |
| JP (1) | JP5513893B2 (enExample) |
| CN (1) | CN101622017B (enExample) |
| AT (1) | ATE545436T1 (enExample) |
| AU (1) | AU2007336692B2 (enExample) |
| BR (1) | BRPI0722061B8 (enExample) |
| CA (1) | CA2673323C (enExample) |
| CY (1) | CY1112623T1 (enExample) |
| DK (1) | DK2107913T3 (enExample) |
| ES (1) | ES2391862T3 (enExample) |
| PL (1) | PL2107913T3 (enExample) |
| PT (1) | PT2107913E (enExample) |
| RU (1) | RU2432181C2 (enExample) |
| SI (1) | SI2107913T1 (enExample) |
| WO (1) | WO2008077172A2 (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3287804B2 (ja) | 1998-07-23 | 2002-06-04 | 株式会社ミツバ | ワイパ装置の取付け構造 |
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| DK2818184T3 (en) | 2007-11-16 | 2019-02-25 | Allergan Inc | Compositions and methods for the treatment of purple |
| US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
| US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| EP2324064B1 (en) | 2008-09-02 | 2017-11-08 | Tautona Group LP | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| CN101721349B (zh) | 2008-10-16 | 2011-07-20 | 常州百瑞吉生物医药有限公司 | 可注射原位交联水凝胶及其制备方法和用途 |
| CZ302503B6 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace |
| CZ302504B6 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
| JP5749283B2 (ja) * | 2010-03-12 | 2015-07-15 | アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエAllergan Industrie Sas | 皮膚状態を改善するための流体組成物 |
| ES2729994T3 (es) | 2010-03-22 | 2019-11-07 | Allergan Inc | Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando |
| US8716204B2 (en) | 2010-07-27 | 2014-05-06 | Zimmer, Inc. | Synthetic synovial fluid compositions and methods for making the same |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| CN102399295B (zh) | 2010-09-09 | 2013-11-06 | 常州百瑞吉生物医药有限公司 | 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途 |
| CZ20101001A3 (cs) | 2010-12-31 | 2012-02-08 | Cpn S.R.O. | Hyaluronová vlákna, zpusob jejich prípravy a použití |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| EP2714002B1 (en) | 2011-06-03 | 2019-04-03 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| JP5871000B2 (ja) * | 2011-06-27 | 2016-03-01 | 日油株式会社 | ポリマー及びその製造方法 |
| EP2545925B1 (en) * | 2011-07-12 | 2018-02-14 | Holy Stone Healthcare Co.,Ltd. | Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| CZ303879B6 (cs) | 2012-02-28 | 2013-06-05 | Contipro Biotech S.R.O. | Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití |
| CZ304512B6 (cs) | 2012-08-08 | 2014-06-11 | Contipro Biotech S.R.O. | Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití |
| CZ2012842A3 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
| US9782345B2 (en) | 2013-10-17 | 2017-10-10 | Jade Therapeutics, Inc. | Ocular composition and method |
| CZ2014150A3 (cs) | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
| SG11201608402WA (en) * | 2014-05-07 | 2016-11-29 | Croma Pharma Ges M B H | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
| EP3620184A1 (en) | 2014-09-30 | 2020-03-11 | Allergan Industrie, SAS | Stable hydrogel compositions including additives |
| WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
| KR20170118105A (ko) | 2015-02-13 | 2017-10-24 | 알러간 인더스트리 에스에이에스 | 턱과 같은 얼굴 이목구비를 조각, 확대 또는 교정하기 위한 임플란트 |
| CZ309295B6 (cs) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
| CZ306479B6 (cs) | 2015-06-15 | 2017-02-08 | Contipro A.S. | Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin |
| CZ306662B6 (cs) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití |
| JP2018532753A (ja) | 2015-10-30 | 2018-11-08 | クロマ−ファーマ ゲゼルシャフト エム.ベー.ハー. | 滅菌水性点眼液の治療的使用 |
| CA3001634C (en) | 2015-10-30 | 2023-05-23 | Croma-Pharma Gesellschaft M.B.H. | Therapeutic use of a sterile aqueous ophthalmic solution |
| CN105537002A (zh) * | 2015-12-17 | 2016-05-04 | 昆明孚锐特经贸有限公司 | 一种硫化铜钼混合精矿浮选分离抑制剂的制备和应用 |
| ITUA20164153A1 (it) * | 2016-06-07 | 2017-12-07 | Jointherapeutics S R L | Composizioni polisaccaridiche impiegabili nella riparazione tissutale |
| CZ308106B6 (cs) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití |
| AR110125A1 (es) * | 2016-11-07 | 2019-02-27 | Croma Pharma Ges M B H | Compuestos poliméricos que liberan sulfuro de hidrógeno |
| EP3618803A1 (en) | 2017-05-03 | 2020-03-11 | Croma-Pharma GmbH | Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders |
| KR102852956B1 (ko) * | 2018-06-15 | 2025-09-03 | 크로마-파르마 게엠베하 | 안정화된 히알루론산 |
| IL279447B2 (en) * | 2018-06-15 | 2025-05-01 | Croma Pharma Gmbh | A hydrogel-based preparation containing a cross-linked polymer |
| CN110279610B (zh) * | 2019-06-26 | 2021-06-11 | 常州百瑞吉生物医药有限公司 | 一种透明质酸皮肤保护组合物及其制备方法和应用 |
| ES2985960T3 (es) | 2019-12-19 | 2024-11-07 | Croma Pharma Gmbh | Hialuronano modificado con tiol e hidrogel que comprende el hialuronano reticulado |
| CN113134116B (zh) * | 2020-01-20 | 2022-09-06 | 山东威高宏瑞医学科技有限公司 | 内镜微创手术用的填充组合物及填充制剂 |
| CA3206171A1 (en) * | 2020-12-30 | 2022-07-07 | Convatec Technologies Inc. | Surface treatment system and method for subcutaneous device |
| CN119798798A (zh) * | 2025-01-09 | 2025-04-11 | 常州百瑞吉生物医药股份有限公司 | 水性溶液透明质酸寡糖组合物的制备方法及组合物、应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4716224A (en) | 1984-05-04 | 1987-12-29 | Seikagaku Kogyo Co. Ltd. | Crosslinked hyaluronic acid and its use |
| US4713448A (en) | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
| EP0784487A1 (en) * | 1993-03-19 | 1997-07-23 | Medinvent | A composition and a method for tissue augmentation |
| FR2727117A1 (fr) | 1994-11-18 | 1996-05-24 | Geffard Michel | Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun |
| US6214331B1 (en) | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
| US5785642A (en) | 1996-10-18 | 1998-07-28 | Micro Therapeutics, Inc. | Methods for treating urinary incontinence in mammals |
| US6630457B1 (en) * | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| US6620927B2 (en) * | 2001-02-22 | 2003-09-16 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
| US6610810B2 (en) * | 2001-03-13 | 2003-08-26 | Glyn Owen Phillips | Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere |
| ITMI20011238A1 (it) * | 2001-06-12 | 2002-12-12 | Bartholdy Consultadoria E Serv | Polimeri polisaccaridici di origine naturale coniugati chimicamente asostanze farmacologicamente o biologicamente attive e loro proprieta' |
| ATA13842001A (de) | 2001-08-31 | 2002-10-15 | Mucobiomer Biotechnologische F | Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung |
| GB2386900B (en) | 2002-03-25 | 2006-11-01 | Johnson & Johnson Medical Ltd | Use in wound dressings of chemically modified polysaccharides |
| US20050176620A1 (en) * | 2002-06-21 | 2005-08-11 | Prestwich Glenn D. | Crosslinked compounds and methods of making and using thereof |
| WO2004073759A1 (en) | 2003-02-19 | 2004-09-02 | Aventis Pharmaceuticals Holdings Inc. | Composition and method for intradermal soft tissue augmentation |
| US20050282747A1 (en) * | 2003-10-01 | 2005-12-22 | The Research Foundation Of State University Of New York At Stony Brook | Methods and compositions for wound healing |
| CA2574232A1 (en) | 2004-07-22 | 2006-01-26 | Thiomatrix Forschungs - Und Beratungs Gmbh | Use of compounds containing thiol groups as an efflux pump inhibitor |
| EP1817347B1 (en) | 2004-11-24 | 2017-05-17 | Albumedix A/S | Method of cross-linking hyaluronic acid with divinylsulfone |
| US20070087059A1 (en) * | 2005-10-17 | 2007-04-19 | Frank Everaerts | Bioactive delivery matrix compositions and methods |
| FR2920671B1 (fr) * | 2007-09-07 | 2010-08-13 | Cousin Biotech | Implant textile, notamment pour la refection des hernies |
-
2007
- 2007-12-21 SI SI200730903T patent/SI2107913T1/sl unknown
- 2007-12-21 DK DK07855366.6T patent/DK2107913T3/da active
- 2007-12-21 ES ES07855366T patent/ES2391862T3/es active Active
- 2007-12-21 JP JP2009541680A patent/JP5513893B2/ja active Active
- 2007-12-21 WO PCT/AT2007/000585 patent/WO2008077172A2/en not_active Ceased
- 2007-12-21 RU RU2009128235/15A patent/RU2432181C2/ru active
- 2007-12-21 AT AT07855366T patent/ATE545436T1/de active
- 2007-12-21 BR BRPI0722061A patent/BRPI0722061B8/pt active IP Right Grant
- 2007-12-21 PT PT07855366T patent/PT2107913E/pt unknown
- 2007-12-21 CA CA2673323A patent/CA2673323C/en active Active
- 2007-12-21 US US12/520,820 patent/US9597277B2/en active Active
- 2007-12-21 AU AU2007336692A patent/AU2007336692B2/en active Active
- 2007-12-21 PL PL07855366T patent/PL2107913T3/pl unknown
- 2007-12-21 CN CN200780047621.3A patent/CN101622017B/zh active Active
- 2007-12-21 EP EP07855366A patent/EP2107913B1/en active Active
-
2012
- 2012-04-09 CY CY20121100352T patent/CY1112623T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512859A5 (enExample) | ||
| RU2009128235A (ru) | Применение полимеров | |
| JP7263459B2 (ja) | 癒着予防のためのハイドロゲル膜 | |
| JP6397491B2 (ja) | キトサンステント材ペースト | |
| JP2013517263A5 (enExample) | ||
| JP5711113B2 (ja) | チオール化キトサンゲル | |
| CN102846655A (zh) | 一种抗菌喷雾剂的配方与制备方法 | |
| JP6446462B2 (ja) | メピバカインを含有するヒアルロン酸組成物 | |
| JP2011521969A5 (enExample) | ||
| JP2010512220A5 (enExample) | ||
| JP2007513959A5 (enExample) | ||
| JP2011522879A5 (enExample) | ||
| US9192692B2 (en) | Chitosan stenting paste | |
| AU2014340006A1 (en) | Chitosan stenting paste | |
| WO2005072745A3 (en) | Aqueous solutions comprising prednisolone and a cyclodextrin derivative | |
| JP2005513106A5 (enExample) | ||
| JP2006516272A (ja) | 医薬品組成物 | |
| HRP20221427T1 (hr) | Kompozicije i postupci za liječenje rana | |
| CO6230979A2 (es) | Uso de quitosanas para incrementar el indice de crecimiento de las uñas | |
| KR101680895B1 (ko) | 구강용 연고 | |
| JP5518608B2 (ja) | 粘膜適用液状組成物 | |
| RU2017142710A (ru) | Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей | |
| AU2019221126B2 (en) | Multi-use torasemide composition | |
| TW201720450A (zh) | 眼科組成物 | |
| HRP20150618T1 (hr) | Visokoelastiäśni gelovi pri operacijama oka |